Maas Biolab is an early stage neuropharmaceutical company. Maas seeks investment to develop cyclosporin formulations and perform phase 2a clinical trials for amyotrophic lateral sclerosis (ALS).

For a business plan please contact Maas Management (see CONTACT US).